0%
Global Oncology Update Series 2 featuring Programme Director Dr. Shuchita Pathak (DMCH Ludhiana) on 18th July 2026 from 18:30 to 21:30 via Zoom.
Global Oncology Update Series 2 is an educational webinar led by Programme Director Dr. Shuchita Pathak (Assistant Professor, Medical Oncology, DMCH Medical College, Ludhiana). Dr. Pathak is an accomplished Consultant Medical Oncologist & Hemato-Oncologist with extensive experience from AIIMS New Delhi and Sir H.N. Reliance Foundation Hospital. Scientific agenda includes: Tecentriq SC: Pioneering Innovative in NSCLC with subcutaneous Immunotherapy (Sponsored by ROCHE) by Dr. Midhila Baby; TISHTHA Session (Sponsored by Zydus) by Dr. Parikshith Jayaprakash; Session on Hetronifly (Sponsored by Intas) by Dr. Gurvinder; Sequencing Strategies in Metastatic Colorectal Cancer (Sponsored by Alkem) by Dr. Shuchita Pathak; and GI Cancer: Advancements in Precision Oncology for Colorectal & Gastric Cancer by Dr. Sudeep Gupta. Contact Sakshee (9152500322) or Udit (9004599174) for details.
The primary aim of Global Oncology Update Series 2 (Dr. Shuchita Pathak) is to deliver updated, evidence-based scientific insights into gastrointestinal oncology, including advanced management strategies for colorectal, esophageal, gastric, and hepato-pancreato-biliary malignancies. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured virtual webinar & interactive online forum. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Gastrointestinal Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Gastrointestinal Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.